AI assistant
Sending…
ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2010
Jul 8, 2010
33882_dirs_2010-07-08_f3d3d1f2-6b61-4775-a417-43b4c48bb0df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2010-07-06
Reporting Person: MARTINO MICHAEL A (Former Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-07-06 | Common Stock | M | 2557 | $7.25 | Acquired | 13557 | Direct |
| 2010-07-06 | Common Stock | S | 2557 | $13.02 | Disposed | 11000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-07-06 | Stock option (right to buy) | $7.25 | M | 2557 | Disposed | 2016-05-12 | Common Stock (2557) | Direct |
More from ACHIEVE LIFE SCIENCES, INC.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 16
Annual Report
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30